SOX9 and cancer: showed that the antioxidative factor iASPP drives cancer growth and drug resistance by competing with NRF2 for KEAP1 binding via DLT.[43] Interestingly, SOX9 contains a DLK motif that resembles DLG in NRF2 or DLT in iASSP, but has no ETGE‐like motif.